Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 14,326–14,350 of 27,380 studies, newest first · page 574 of 1096.

January 2018 25

  1. 2018-01-15

    New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation

    ✓ Peer-reviewed Clinical trials British journal of pharmacology

    Key finding: Clinically meaningful effects of melatonin treatment have been demonstrated in placebo-controlled trials in humans, particularly in disorders associated with diminished or misaligned melatonin rhythms, for example, circadian rhythm-related sleep disorders, jet lag and shift work, insomnia in children with neurodevelopmental disorders, poor (non-restorative) sleep quality, non-dipping nocturnal blood pressure (nocturnal hypertension) and Alzheimer's disease (AD). +1 more finding

  2. 2018-01-15

    Causal associations between risk factors and common diseases inferred from GWAS summary data

    ✓ Peer-reviewed Genetics Nature communications

    Key finding: Health risk factors such as body mass index (BMI) and serum cholesterol are associated with many common diseases. +1 more finding

  3. 2018-01-15

    Dietary salt promotes neurovascular and cognitive dysfunction through a gut-initiated TH17 response

    ✓ Peer-reviewed Prevention and risk Nature neuroscience

    Key finding: A diet rich in salt is linked to an increased risk of cerebrovascular diseases and dementia, but it remains unclear how dietary salt harms the brain. +1 more finding

  4. 2018-01-14

    Person-specific contribution of neuropathologies to cognitive loss in old age

    ✓ Peer-reviewed How common it is Annals of neurology

    Key finding: Neuropathology was ubiquitous, with 94% of participants having 1+, 78% having 2+, 58% having 3+, and 35% having 4+.

  5. 2018-01-13
  6. 2018-01-12

    Longitudinal Association of Amyloid Beta and Anxious-Depressive Symptoms in Cognitively Normal Older Adults

    ✓ Peer-reviewed Brain scans and imaging The American journal of psychiatry

    Key finding: Higher amyloid beta burden was associated with increasing anxious-depressive symptoms over time in cognitively normal older individuals. +3 more findings

  7. 2018-01-12

    Application of Metabolomics in Alzheimer's Disease

    ✓ Peer-reviewed Genetics Frontiers in neurology

    Key finding: Advancements in the field of metabolomics have demonstrated the complexity of dynamic changes associated with AD progression underscoring challenges with the development of efficacious therapeutic interventions.

  8. 2018-01-12

    Noncoding RNAs in Alzheimer's disease

    ✓ Peer-reviewed Caregiving Wiley interdisciplinary reviews. RNA

    Key finding: However, the full spectrum of molecular factors that contribute to AD pathogenesis is not known. +4 more findings

  9. 2018-01-11

    Differential Effects of Alzheimer's Disease Aβ40 and 42 on Endocytosis and Intraneuronal Trafficking

    ✓ Peer-reviewed Biomarkers Neuroscience

    Key finding: We have shown substantial down-regulation of KEGG endocytotic pathway genes in AD patient brain regions that accumulate Aβ compared to those in non-demented individuals. +2 more findings

  10. 2018-01-11

    Brain Photobiomodulation Therapy: a Narrative Review

    ✓ Peer-reviewed Vascular contributions Molecular neurobiology

    Key finding: Moreover, light absorption by ion channels results in release of Ca 2+ and leads to activation of transcription factors and gene expression.

  11. 2018-01-11
  12. 2018-01-11

    CSF neurogranin or tau distinguish typical and atypical Alzheimer disease

    ✓ Peer-reviewed Biomarkers Annals of clinical and translational neurology

    Key finding: These results show significant differences in neurogranin and total-tau between typical and atypical patients, which may relate to factors other than disease topography. +3 more findings

  13. 2018-01-10

    Reprogramming neurodegeneration in the big data era

    ✓ Peer-reviewed Genetics Current opinion in neurobiology

    Key finding: Recent genome-wide association studies (GWAS) have identified numerous genetic risk variants for late-onset Alzheimer's disease (AD) and Parkinson's disease (PD). +4 more findings

  14. 2018-01-10

    Association Between Sensory Impairment and Dementia in Older Adults: Evidence from China

    ✓ Peer-reviewed Risk factors Journal of the American Geriatrics Society

    Key finding: Sensory impairments are associated with greater risk of dementia in Chinese older adults. +3 more findings

  15. 2018-01-10

    Amyloid β causes excitation/inhibition imbalance through dopamine receptor 1-dependent disruption of fast-spiking GABAergic input in anterior cingulate cortex

    ✓ Peer-reviewed Disease mechanisms Scientific reports

    Key finding: Here by using whole-cell recordings in acute mouse brain slices, we found that 50 nM Aβ induces hyperexcitability of excitatory pyramidal cells in the cingulate cortex, one of the most vulnerable areas in AD, via depressing inhibitory synaptic transmission. +1 more finding

  16. 2018-01-10

    The rs75932628 and rs2234253 polymorphisms of the TREM2 gene were associated with susceptibility to frontotemporal lobar degeneration in Caucasian populations

    ✓ Peer-reviewed TREM2 and immune genetics Annals of human genetics

    Key finding: Polymorphisms of the triggering receptor expressed on myeloid cells 2 (TREM2) gene have been reported to be potentially associated with the risks of developing frontotemporal lobar degeneration (FTLD), with inconsistent conclusions. +3 more findings

  17. 2018-01-10

    Cerebrospinal fluid Alzheimer biomarkers can be useful for discriminating dementia with Lewy bodies from Alzheimer's disease at the prodromal stage

    ✓ Peer-reviewed Tau biomarkers Journal of neurology, neurosurgery, and psychiatry

    Key finding: Differential diagnosis between dementia with Lewy bodies (DLB) and Alzheimer's disease (AD) is not straightforward, especially in the early stages of disease. +3 more findings

  18. 2018-01-10

    Humanized TREM2 mice reveal microglia-intrinsic and -extrinsic effects of R47H polymorphism

    ✓ Peer-reviewed TREM2 and immune genetics The Journal of experimental medicine

    Key finding: The R47H variant of the microglial receptor TREM2 triples AD risk in genome-wide association studies. +3 more findings

  19. 2018-01-10

    Use of multimodality imaging and artificial intelligence for diagnosis and prognosis of early stages of Alzheimer's disease

    ✓ Peer-reviewed Digital health tools Translational research : the journal of laboratory and clinical medicine

    Key finding: Making a diagnosis of AD and offering a prognosis (likelihood of converting to AD) at these early stages are challenging tasks but possible with the help of multimodality imaging, such as magnetic resonance imaging (MRI), fluorodeoxyglucose (FDG)-positron emission topography (PET), amyloid-PET, and recently introduced tau-PET, which provides different but complementary information. +4 more findings

  20. 2018-01-10

    Comparing 18F-AV-1451 with CSF t-tau and p-tau for diagnosis of Alzheimer disease

    ✓ Peer-reviewed Brain scans and imaging Neurology

    Key finding: CSF tau and 18 F-AV-1451 have equal performance in early clinical stages of AD, but 18 F-AV-1451 is superior in the dementia stage, and exhibits close to perfect diagnostic performance for mild to moderate AD. +2 more findings

  21. 2018-01-10

    Diet, nutrition and the ageing brain: current evidence and new directions

    ✓ Peer-reviewed Prevention and risk The Proceedings of the Nutrition Society

    Key finding: There is some evidence linking certain dietary patterns, particularly the Mediterranean diet, with a reduced risk of dementia and depression. +4 more findings

  22. 2018-01-10

    Falls in Cognitively Impaired Older Adults: Implications for Risk Assessment And Prevention

    ✓ Peer-reviewed Prevention and risk Journal of the American Geriatrics Society

    Key finding: Falls remain common in older people, with higher prevalence and morbidity in those who are cognitively impaired.

  23. 2018-01-09

    Therapeutic potential of spinal GLP-1 receptor signaling

    ✓ Peer-reviewed Drug development Peptides

    Key finding: GLP-1R is expressed in multiple organs and numerous experimental studies have demonstrated that GLP-1 signaling pathway exhibits pro-survival functions in various disorders. +2 more findings

  24. 2018-01-09

    Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies

    ✓ Peer-reviewed Inflammation and the immune system PLoS medicine

    Key finding: We found up to 270-fold genetic enrichment between FTD and RA, up to 160-fold genetic enrichment between FTD and UC, up to 180-fold genetic enrichment between FTD and T1D, and up to 175-fold genetic enrichment between FTD and CeD. +4 more findings

  25. 2018-01-09

    Slowly progressive dementia caused by MAPT R406W mutations: longitudinal report on a new kindred and systematic review

    ✓ Peer-reviewed Disease mechanisms Alzheimer's research & therapy

    Key finding: Dominance of 4R over three-repeat (exon 10-) tau isoforms contrasts with earlier reports of R406W patients and was not sufficiently explained by the presence of H1/H2 haplotypes in two of the autopsied patients. +2 more findings

Browse the library by subject, with the full score breakdown →